治療用ボツリヌス毒素の世界市場：Medtech 360

世界のBTX治療手技の件数、また製品の売上と収益は、既存患者が維持手技のために再来院する必要性と、希少な適応症の拡大による新規患者の需要の増加によって支えられる見込みです。

新たな適応症の承認と既存の適応症の拡大は、治療用BTX市場の重要な促進要因となります。

世界のBTX治療薬市場はますます統合されつつあります。

地域ごとに市場規模や成長は大きく異なりますが、米国市場が世界でもっとも急速に拡大しています。

当レポートでは、世界の治療用ボツリヌス毒素市場について調査分析し、2019年～2033年の市場情勢に関する包括的なデータと分析を提供しています。

目次

世界

要約

エグゼクティブサマリー

• COVID-19最新情報
• 市場ハイライト
• 競合ハイライト
• 市場の発展
• 対象地域
• 対象手技
• 対象製品

主なレポートの更新

世界のボツリヌス毒素治療市場

• 市場のハイライト
  • 主なコンテンツの更新
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合考察
  • Allergan (an AbbVie company)
  • Merz Pharma
  • Ipsen
  • GlaxoSmithKline
  • Supernus Pharmaceuticals
  • その他の主な競合
  • すべての競合に影響を与える要因
• 市場動向

米国の治療用ボツリヌス毒素市場

• 市場のハイライト
  • 主なコンテンツの更新
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合考察
  • 米国の治療用ボツリヌス毒素市場の競合考察
  • すべての競合に影響を与える要因

欧州の治療用ボツリヌス毒素市場

• 市場のハイライト
  • 主なコンテンツの更新
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合考察
  • 欧州の治療用ボツリヌス毒素市場の競合考察

アジア太平洋の治療用ボツリヌス毒素市場

• 市場のハイライト
  • 主なコンテンツの更新
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合考察
  • アジア太平洋の治療用ボツリヌス毒素市場の競合考察
  • すべての競合に影響を与える要因

付録

調査手法

Global therapeutic BTX procedure volumes-and thus product sales and revenues-will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand among new patients driven by expanding rare indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for therapeutic BTX in the US, Europe, and the Asia Pacific region from 2019 through 2033.

New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.

• Which indications contribute the most to growth, and which have the largest market growth potential?
• What regional differences exist regarding indication approvals, and what are the new indications approved in each region?
• Which competitors have been targeting these indications?
• Are there any significant changes in competitive landscape ?

Global therapeutic BTX markets are becoming increasingly consolidated.

• What are some key competitive strategies currently being leveraged or can potentially be employed to succeed in the market?
• How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest expansion globally.

• What key drivers are contributing to each regional market's relative size and growth?
• How does pricing vary by region, and what factors most significantly affect pricing within each market?
• How does the reimbursement of therapeutic BTX products influence the pricing and adoption of these products across different indications and geographies?
• How are the increasing cases of different indication impacting the units sales and market values?

Table of Contents

Global

Abstract

Executive Summary

• COVID-19 Updates
• Market Highlights
• Competitive Highlights
• Market Developments
• Geographies Covered
• Procedures Covered
• Products Covered

Key Report Updates

Global Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Allergan (an AbbVie company)
  • Merz Pharma
  • Ipsen
  • GlaxoSmithKline
  • Supernus Pharmaceuticals
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

US Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors

European Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • European Therapeutic Botulinum Toxin Market Competitive Insights

Asia Pacific Therapeutic Botulinum Toxin Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Asia Pacific Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors

Appendix

• Abbreviations
• Bibliography

Methodology

• Core Country Coverage Methodology
• Research Methodology
• Marketrack Methodology
• PriceTrack Methodology
• Forecast Methodology
• Supplemental Country Coverage Methodology
• Base-Year Ratio Analysis
• Market Forecasting

Tables and figures

• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Market Landscape, Global (USD), 2023 and 2033
• Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2023
• Competitive Insights
• Companies Mentioned
• Recent Events in the Therapeutic BTX Market, Global
• Key Clinical Trials in the Therapeutic BTX Market, Global
• Emerging Products for the Therapeutic BTX Market, Global
• Geographies Covered, Global
• Average Currency Exchange Rates
• Therapeutic BTX Procedures Covered, US
• Approved Indications, by Brand, US, 2022/2023
• Therapeutic BTX Procedures Covered, Europe
• Approved Indications, by Brand, Europe, 2022/2023
• Therapeutic BTX Procedures Covered, Asia Pacific
• Approved Indications, by Brand, Asia Pacific, 2022/2023
• Therapeutic BTX Product Overview, Global, 2022/2023
• Global Therapeutic Botulinum Toxin Market Drivers
• Global Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Product Overview, Global, 2022/2023
• Mean Dosages, by Indication and Brand, Global
• BTX Units Used per Procedure, by Indication, Global
• BTX Product Equivalencies, by Brand
• Approved Indications, by Brand, US, 2022/2023
• Approved Indications, by Brand, Europe, 2022/2023
• Approved Indications, by Brand, Asia Pacific, 2022/2023
• Therapeutic BTX Procedures, by Indication, Global, 2019-2033
• Therapeutic BTX Procedures, by Region, Global, 2019-2033
• Therapeutic BTX Market, by Indication, Global (USD), 2019-2033
• Therapeutic BTX Market, by Region, Global (USD), 2019-2033
• Therapeutic BTX Market Growth, by Region, Global, 2019-2033
• Therapeutic BTX Revenue Market Shares, Global, 2023
• Therapeutic BTX Revenue Market Shares, by Region, Global, 2023
• Allergan (an AbbVie company) Competitive Insights
• Merz Pharma Competitive Insights
• Ipsen Competitive Insights
• GlaxoSmithKline Competitive Insights
• Supernus Pharmaceuticals Competitive Insights
• Competitive Insights for Other Key Competitors
• Recent Events in the Therapeutic BTX Market, Global
• Key Clinical Trials in the Therapeutic BTX Market, Global
• Emerging Products for the Therapeutic BTX Market, Global
• US Therapeutic Botulinum Toxin Market Drivers
• US Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, US (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, US, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019-2033
• Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019-2033
• Therapeutic BTX Market, by Indication, US (USD), 2019-2033
• Therapeutic BTX Market, US (USD), 2019-2033
• Therapeutic BTX Revenue Market Shares, US 2023
• Therapeutic BTX Revenue Market Shares, US, 2023
• European Therapeutic Botulinum Toxin Market Drivers
• European Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Country, Europe (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, Europe, 2019-2033
• Therapeutic BTX Procedures, by Country, Europe, 2019-2033
• Therapeutic BTX Procedures, by Indication, France, 2019-2033
• Therapeutic BTX Procedures, by Indication, Germany, 2019-2033
• Therapeutic BTX Procedures, by Indication, Italy, 2019-2033
• Therapeutic BTX Procedures, by Indication, Spain, 2019-2033
• Therapeutic BTX Procedures, by Indication, UK, 2019-2033
• Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Country, Europe (USD), 2019-2033
• Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019-2033
• Therapeutic BTX Market Growth, by Country, Europe, 2020-2033
• Therapeutic BTX Market, by Indication, France (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019-2033
• Therapeutic BTX Market, by Indication, UK (GBP), 2019-2033
• Therapeutic BTX Revenue Market Shares, Europe, 2023
• Therapeutic BTX Revenue Market Shares, by Country, Europe, 2023
• Asia Pacific Therapeutic Botulinum Toxin Market Drivers
• Asia Pacific Therapeutic Botulinum Toxin Market Limiters
• Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019-2033
• Therapeutic BTX Procedures, by Country, Asia Pacific, 2019-2033
• Therapeutic BTX Procedures, by Indication, Australia, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019-2033
• Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019-2033
• Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019-2033
• Therapeutic BTX Procedures, by Indication, Japan, 2019-2033
• Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2033
• Therapeutic BTX Market, by Indication, Australia (USD), 2019-2033
• Therapeutic BTX Market, Australia (USD), 2019-2033
• Therapeutic BTX Market, by Indication, Japan (USD), 2019-2033
• Therapeutic BTX Market, Japan (USD), 2019-2033
• Therapeutic BTX Revenue Market Shares, Asia Pacific, 2023
• Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2023